Literature DB >> 1588560

Probes for the cocaine receptor. Potentially irreversible ligands for the dopamine transporter.

F I Carroll1, Y Gao, P Abraham, A H Lewin, R Lew, A Patel, J W Boja, M J Kuhar.   

Abstract

Several potentially irreversible ligands (i.e., wash-resistant binding inhibitors) for the cocaine receptor site on the dopamine transporter, derived from (-)-cocaine or 3 beta-phenyltropan-2 beta-carboxylic acid methyl ester (WIN 35,065-2), were prepared and shown to produce wash-resistant inhibition of [3H]-3 beta-(p-fluorophenyl)tropan-2 beta-carboxylic acid methyl ester ([3H]WIN 35,428) binding. All the compounds prepared had the same absolute configuration as cocaine; they include analogues possessing chemically reactive groups such as the isothiocyanato and bromoacetamido as well as photoactive azido groups. The potentially irreversible ligands, as well as all the intermediates prepared in this study, were evaluated for their ability to inhibit the binding of [3H]WIN 35,428 in coincubation experiments. Of the potentially irreversible ligands, 3 beta-(p-chlorophenyl)tropan-2 beta-carboxylic acid 2-[p-(bromoacetamido)phenyl]ethyl ester (6c) had the highest apparent potency. The potentially irreversible ligands were also preincubated, and inhibition of [3H]WIN 35,428 binding was determined both before and after washing the ligand-exposed tissues. The most effective ligands in this regard were 3 beta-(3-iodo-4-azidophenyl)tropan-2 beta-carboxylic acid methyl ester (5) and 3 beta-(p-chlorophenyl)tropan-2 beta-carboxylic acid 2-(3-iodo-4-azidophenyl)ethyl ester (6d). The structure-activity relationships of these data are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1588560     DOI: 10.1021/jm00088a017

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

1.  Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.

Authors:  Chunyang Jin; Hernán A Navarro; F Ivy Carroll
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

2.  The last step in cocaine biosynthesis is catalyzed by a BAHD acyltransferase.

Authors:  Gregor Wolfgang Schmidt; Jan Jirschitzka; Tiffany Porta; Michael Reichelt; Katrin Luck; José Carlos Pardo Torre; Franziska Dolke; Emmanuel Varesio; Gérard Hopfgartner; Jonathan Gershenzon; John Charles D'Auria
Journal:  Plant Physiol       Date:  2014-11-18       Impact factor: 8.340

3.  Azido-iodo-N-benzyl derivatives of threo-methylphenidate (Ritalin, Concerta): Rational design, synthesis, pharmacological evaluation, and dopamine transporter photoaffinity labeling.

Authors:  David J Lapinsky; Ranganadh Velagaleti; Nageswari Yarravarapu; Yi Liu; Yurong Huang; Christopher K Surratt; John R Lever; James D Foster; Rejwi Acharya; Roxanne A Vaughan; Howard M Deutsch
Journal:  Bioorg Med Chem       Date:  2010-11-04       Impact factor: 3.641

4.  Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo in the rat.

Authors:  J C Régo; M Syringas; B Leblond; J Costentin; J J Bonnet
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

5.  A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone.

Authors:  David J Lapinsky; Shaili Aggarwal; Yurong Huang; Christopher K Surratt; John R Lever; James D Foster; Roxanne A Vaughan
Journal:  Bioorg Med Chem       Date:  2009-05-03       Impact factor: 3.641

6.  Evolution of a Compact Photoprobe for the Dopamine Transporter Based on (±)-threo-Methylphenidate.

Authors:  David J Lapinsky; Nageswari Yarravarapu; Tammy L Nolan; Christopher K Surratt; John R Lever; Michael Tomlinson; Roxanne A Vaughan; Howard M Deutsch
Journal:  ACS Med Chem Lett       Date:  2012-03-11       Impact factor: 4.345

7.  Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site.

Authors:  Rejwi Acharya Dahal; Akula Bala Pramod; Babita Sharma; Danielle Krout; James D Foster; Joo Hwan Cha; Jianjing Cao; Amy Hauck Newman; John R Lever; Roxanne A Vaughan; L Keith Henry
Journal:  J Biol Chem       Date:  2014-08-31       Impact factor: 5.157

8.  Effects of ginseng saponin on acute cocaine-induced alterations in evoked dopamine release and uptake in rat brain nucleus accumbens.

Authors:  Seong-Yeol Nah; Kamal S Bhatia; Johnnie Lyles; Everett H Ellinwood; Tong H Lee
Journal:  Brain Res       Date:  2008-11-08       Impact factor: 3.252

9.  Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.

Authors:  Chunyang Jin; Hernán A Navarro; F Ivy Carroll
Journal:  Bioorg Med Chem       Date:  2009-05-29       Impact factor: 3.641

10.  Irreversible binding of a novel phenylisothiocyanate tropane analog to monoamine transporters in rat brain.

Authors:  Vishakantha Murthy; Huw M L Davies; Simon J Hedley; Steven R Childers
Journal:  Biochem Pharmacol       Date:  2007-04-27       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.